Donepezil (Demenza (10 mg)) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving ...

Donepezil increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil alters the course of the underlying ...

Associate Professor, Department of Medicine, Division of Geriatrics, University of California, Los Angeles; Medical Director, UCLA Alzheimer's and Dementia Care Program, Ronald Reagan UCLA Medical ...

BRIDGEWATER, N.J., January 23, 2025--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has ...

NEW YORK (MedscapeWire) Apr 19 — Donepezil ( Aricept) isn't just for Alzheimer's anymore. Results of a randomized, placebo-controlled trial presented April 17 at the American Academy of Neurology 54th ...

SAN DIEGO — A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia, per a presenter at the Alzheimer’s ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

Abbreviations: COWA, Controlled Oral Word Association Test; DST, Digit Span Test; GP, Grooved Pegboard; HVLT-R, Hopkins Verbal Learning Test–Revised; LS, least ...

The cholinergic system plays a major role in cognitive abilities that are essential to piloting an aircraft: attention, learning, and memory. In previous studies, drugs that enhance the cholinergic ...

Background A 78-year-old man with a 22-year history of schizoaffective disorder and a 5-year history of dementia presented to the emergency department with a 5-day history of fatigue, progressive ...

WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)-- Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...